Health Catalyst, Inc.
HCAT
$1.10
-$0.12-9.50%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 311.14M | 316.06M | 316.09M | 311.27M | 306.58M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 311.14M | 316.06M | 316.09M | 311.27M | 306.58M |
| Cost of Revenue | 156.50M | 165.96M | 170.69M | 168.28M | 164.79M |
| Gross Profit | 154.63M | 150.11M | 145.41M | 143.00M | 141.79M |
| SG&A Expenses | 94.15M | 97.16M | 96.54M | 94.90M | 99.01M |
| Depreciation & Amortization | 50.50M | 47.88M | 45.25M | 43.23M | 41.43M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 347.24M | 362.13M | 366.71M | 362.33M | 362.04M |
| Operating Income | -36.10M | -46.07M | -50.61M | -51.05M | -55.45M |
| Income Before Tax | -177.26M | -106.66M | -99.67M | -72.22M | -69.17M |
| Income Tax Expenses | 716.00K | 962.00K | 446.00K | 435.00K | 333.00K |
| Earnings from Continuing Operations | -177.97 | -107.62 | -100.12 | -72.66 | -69.50 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -177.97M | -107.62M | -100.12M | -72.66M | -69.50M |
| EBIT | -36.10M | -46.07M | -50.61M | -51.05M | -55.45M |
| EBITDA | 1.90M | -9.78M | -16.26M | -18.03M | -23.72M |
| EPS Basic | -2.53 | -1.58 | -1.51 | -1.15 | -1.15 |
| Normalized Basic EPS | -0.47 | -0.56 | -0.59 | -0.56 | -0.57 |
| EPS Diluted | -2.53 | -1.58 | -1.51 | -1.15 | -1.15 |
| Normalized Diluted EPS | -0.47 | -0.56 | -0.59 | -0.56 | -0.57 |
| Average Basic Shares Outstanding | 279.55M | 270.93M | 261.00M | 250.67M | 240.71M |
| Average Diluted Shares Outstanding | 279.55M | 270.93M | 261.00M | 250.67M | 240.71M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |